| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | ISOX | CTRPv2 | pan-cancer | AAC | -0.069 | 0.03 |
| mRNA | tubastatin A | GDSC1000 | pan-cancer | AAC | -0.068 | 0.03 |
| mRNA | Erlotinib | CTRPv2 | pan-cancer | AAC | -0.075 | 0.03 |
| mRNA | PHA-665752 | GDSC1000 | pan-cancer | AAC | -0.11 | 0.04 |
| mRNA | SB-225002 | CTRPv2 | pan-cancer | AAC | -0.066 | 0.04 |
| mRNA | C6-ceramide | CTRPv2 | pan-cancer | AAC | 0.08 | 0.04 |
| mRNA | myricetin | CTRPv2 | pan-cancer | AAC | 0.081 | 0.04 |
| mRNA | bid1870 | gCSI | pan-cancer | AAC | 0.12 | 0.04 |
| mRNA | CIL55A | CTRPv2 | pan-cancer | AAC | -0.11 | 0.04 |
| mRNA | 17-AAG | CCLE | pan-cancer | AAC | -0.098 | 0.04 |